Cyclacel Pharma (CYCC) Tops Q2 EPS by 8c

Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.46), $0.08 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
• Jersey Mike's Subs (JMKE) PT Raised to $29 at Guggenheim